Funding for this research was provided by:
National Health and Medical Research Council (APP1150801)
Multiple Sclerosis Research Australia (170307)
Text and Data Mining valid from 2019-06-14
Received: 26 March 2019
Accepted: 3 June 2019
First Online: 14 June 2019
Ethics approval and consent to participate
: This study has gained ethics approval from the University of Sydney Human Research Ethics Committee (Project No. 2018/402). Informed consent will be completed online in accordance with the approved ethics application.
: Not applicable.
: HB has received compensation for education travel, speaker honoraria and consultant fees from Biogen, Novartis, Merck, Sanofi-Genzyme and Roche. The authors declare no other competing interests.